Abstract
Hybrid core-shell nanoparticles (NPs) have potential applications in X-ray activated photodynamic therapy (X-PDT), where the drug is activated by X-rays due to the NP scintillation, combining radiotherapy (RT) and PDT into a single treatment. X-PDT offers the potential to reduce the dose of X-rays required to cause tumor cell death in RT, minimizing damage to healthy tissues surrounding t…